Search Results
San Antonio Breast Cancer Symposium 2008: New biomarker predicts anthracycline response.
Dr. O'Shaughnessy on the Future of Breast Cancer Biomarkers
An Evening Symposium on Breast Cancer
Dr. Ellis Discusses Ki67 as a Treatment Monitoring Biomarker
Anthracyclines for HER2-Positive Early Breast Cancer
Ki-67 shows proven clinical utility as a predictive clincal biomarkers for breast cancer
Dr. McTiernan on Biomarkers Associated with Poor Prognosis in Breast Cancer
Ken Evans: Biomarker Revolution in Cancer Medicine
Adjuvant Therapy of Breast Cancer
Dr. Tripathy Discusses Breast Cancer Biomarkers
Dr. Pearlstone on Struggles Facing Breast Oncologists
José Baselga,et al: Biomarker Analysis Identified Women Most Likely to Benefit From T-DM1